טנופוביר טבע
teva israel ltd - tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - indicated for the treatment of : 1. hiv 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of hiv.2. chronic hepatitis b in adults with: • compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. • decompensated liver disease.
המליברה 150 מגמל
roche pharmaceuticals (israel) ltd - emicizumab - תמיסה להזרקה - emicizumab 150 mg / 1 ml - emicizumab
המליברה 30 מגמל
roche pharmaceuticals (israel) ltd - emicizumab - תמיסה להזרקה - emicizumab 30 mg / 1 ml - emicizumab
טיסנטריק
roche pharmaceuticals (israel) ltd - atezolizumab - תרכיז להכנת תמיסה לאינפוזיה - atezolizumab 60 mg/ml
טיסנטריק
roche pharmaceuticals (israel) ltd - atezolizumab - תרכיז להכנת תמיסה לאינפוזיה - atezolizumab 60 mg / 1 ml
רפמיון תמיסה
pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.
ליקרביום
rekah pharmaceutical industry ltd, israel - lithium carbonate - טבליה - lithium carbonate 300 mg - lithium - treatment of manic depressive states.
אסברייט 267 מג
roche pharmaceuticals (israel) ltd - pirfenidone - קפסולה קשיחה - pirfenidone 267 mg - pirfenidone
אסברייט 267 מג
roche pharmaceuticals (israel) ltd - pirfenidone - קפסולה קשיחה - pirfenidone 267 mg - pirfenidone
לוסרטה 50
cts chemical industries ltd, israel - losartan potassium - טבליה - losartan potassium 50 mg - losartan - losartan - hypertension: losartan indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losartan is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy. the benefit of losartan on the primary composite end point